NCT05025683 is a clinical trial in Emergency Patients, sponsored by Chinese University of Hong Kong.

Who is sponsoring NCT05025683?

NCT05025683 is sponsored by Chinese University of Hong Kong.

What condition does NCT05025683 study?

NCT05025683 studies Emergency Patients.

Is NCT05025683 still recruiting?

NCT05025683 is currently completed. Last updated 27 August 2021.

Last reviewed 2021-08-27 · How we verify

NCT05025683

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analyzing Patient Flows at the Emergency Department by Data Analytics, Simulation, and Optimization

Completed Last updated 27 August 2021

What this trial tests

trial in Emergency Patients in 23,425 participants. Completed in 20 January 2021.

Timeline

21 January 2019

Primary endpoint
1 December 2020

20 January 2021

Quick facts

Lead sponsor	Chinese University of Hong Kong
Status	Completed
Study type	OBSERVATIONAL
Enrollment	23,425
Start date	21 January 2019
Primary completion	1 December 2020
Estimated completion	20 January 2021
Sites	1 location across Hong Kong

Conditions studied

Emergency Patients — all drugs for Emergency Patients →

Sponsor

Chinese University of Hong Kong

Who can join

Eligibility, any sex, with Emergency Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this project, investigators apply operations research techniques, more specifically data analytics, system simulation, mathematical modelling, and optimization, for analyzing and improving operations in the Emergency Department at the Prince of Wales Hospital. The long term goals of this project are to demonstrate that integrated approach of data analytics and systems thinking is beneficial to health service planning and to extend present work to applications in other health-service systems.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05025683 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 27 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05025683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing